From the BMI paradox to the obesity paradox: the obesity–mortality association in coronary heart disease

Obesity Reviews

Volumn 17, Issue 10, 2016, Pages 989-1000

  Antonopoulos, A S ^a,b   Oikonomou, E K ^a,b   Antoniades, C ^b   Tousoulis, D ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Adipose tissue; body mass index; coronary heart disease; obesity

Indexed keywords

ADIPOSE TISSUE; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COMORBIDITY; DISEASE ASSOCIATION; HUMAN; ISCHEMIC HEART DISEASE; OBESITY; OUTCOME ASSESSMENT; PHENOTYPE; REVIEW;

EID: 84986586582     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12440     Document Type: Review

References (96)

1. Bastien M, Poirier P, Lemieux I, Despres JP. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis 2014; 56: 369–381.
2. Adams KF, Schatzkin A, Harris TB et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006; 355: 763–778.
3. Nazare JA, Smith J, Borel AL et al. Usefulness of measuring both body mass index and waist circumference for the estimation of visceral adiposity and related cardiometabolic risk profile (from the INSPIRE ME IAA study). Am J Cardiol 2015; 115: 307–315.
4. De Schutter A, Lavie CJ, Kachur S, Patel DA, Milani RV. Body composition and mortality in a large cohort with preserved ejection fraction: untangling the obesity paradox. Mayo Clin Proc 2014; 89: 1072–1079.
5. Chrysant SG, Chrysant GS. New insights into the true nature of the obesity paradox and the lower cardiovascular risk. J Am Soc Hypertens 2013; 7: 85–94.
6. Britton KA, Fox CS. Ectopic fat depots and cardiovascular disease. Circulation 2011; 124: e837–e841.
7. Kortelainen ML, Porvari K. Extreme obesity and associated cardiovascular disease verified at autopsy: time trends over 3 decades. Am J Forensic Med Pathol 2011; 32: 372–377.
8. Niraj A, Pradhan J, Fakhry H, Veeranna V, Afonso L. Severity of coronary artery disease in obese patients undergoing coronary angiography: “obesity paradox” revisited. Clin Cardiol 2007; 30: 391–396.
9. Alpert MA, Omran J, Mehra A, Ardhanari S. Impact of obesity and weight loss on cardiac performance and morphology in adults. Prog Cardiovasc Dis 2014; 56: 391–400.
10. Yusuf S, Hawken S, Ounpuu S et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case–control study. Lancet 2005; 366: 1640–1649.
11. Dagenais GR, Yi Q, Mann JF, Bosch J, Pogue J, Yusuf S. Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am Heart J 2005; 149: 54–60.
12. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968–977.
13. Prospective Studies C, Whitlock G, Lewington S et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083–1096.
14. Hainer V, Aldhoon-Hainerova I. Obesity paradox does exist. Diabetes Care 2013; 36(Suppl 2): S276–S281.
15. Standl E, Erbach M, Schnell O. Defending the con side: obesity paradox does not exist. Diabetes Care 2013; 36(Suppl 2): S282–S286.
16. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013; 309: 71–82.
17. Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 2008; 156: 13–22.
18. Doehner W, von Haehling S, Anker SD. Protective overweight in cardiovascular disease: moving from ‘paradox’ to ‘paradigm’. Eur Heart J 2015; 36: 2729–2732.
19. Gruberg L, Weissman NJ, Waksman R et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 2002; 39: 578–584.
20. Romero-Corral A, Montori VM, Somers VK et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006; 368: 666–678.
21. Minutello RM, Chou ET, Hong MK et al. Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry). Am J Cardiol 2004; 93: 1229–1232.
22. Takagi H, Umemoto T, Group A. Overweight, but not obesity, paradox on mortality following coronary artery bypass grafting. J Cardiol 2015 doi: 10.1016/j.jjcc.2015.09.015.
23. Uretsky S, Messerli FH, Bangalore S et al. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med 2007; 120: 863–870.
24. Badheka AO, Rathod A, Kizilbash MA et al. Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox. Am J Med 2010; 123: 646–651.
25. Costanzo P, Cleland JG, Pellicori P et al. The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study. Ann Intern Med 2015; 162: 610–618.
26. Oreopoulos A, McAlister FA, Kalantar-Zadeh K et al. The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH. Eur Heart J 2009; 30: 2584–2592.
27. Dhoot J, Tariq S, Erande A, Amin A, Patel P, Malik S. Effect of morbid obesity on in-hospital mortality and coronary revascularization outcomes after acute myocardial infarction in the United States. Am J Cardiol 2013; 111: 1104–1110.
28. Niedziela J, Hudzik B, Niedziela N et al. The obesity paradox in acute coronary syndrome: a meta-analysis. Eur J Epidemiol 2014; 29: 801–812.
29. Wang L, Liu W, He X et al. Association of overweight and obesity with patient mortality after acute myocardial infarction: a meta-analysis of prospective studies. Int J Obes (Lond) 2016; 40: 220–228.
30. Eisenstein EL, McGuire DK, Bhapkar MV et al. Elevated body mass index and intermediate-term clinical outcomes after acute coronary syndromes. Am J Med 2005; 118: 981–990.
31. Bucholz EM, Rathore SS, Reid KJ et al. Body mass index and mortality in acute myocardial infarction patients. Am J Med 2012; 125: 796–803.
32. Kennedy LM, Dickstein K, Anker SD, Kristianson K, Willenheimer R, Group OS. The prognostic importance of body mass index after complicated myocardial infarction. J Am Coll Cardiol 2005; 45: 156–158.
33. Numasawa Y, Kohsaka S, Miyata H et al. Impact of body mass index on in-hospital complications in patients undergoing percutaneous coronary intervention in a Japanese real-world multicenter registry. PLoS One 2015; 10 e0124399.
34. Bundhun PK, Li N, Chen MH. Does an obesity paradox really exist after cardiovascular intervention?: a systematic review and meta-analysis of randomized controlled trials and observational studies. Medicine (Baltimore) 2015; 94 e1910.
35. Schenkeveld L, Magro M, Oemrawsingh RM et al. The influence of optimal medical treatment on the ‘obesity paradox’, body mass index and long-term mortality in patients treated with percutaneous coronary intervention: a prospective cohort study. BMJ Open 2012; 2 e000535.
36. Benedetto U, Danese C, Codispoti M. Obesity paradox in coronary artery bypass grafting: myth or reality? J Thorac Cardiovasc Surg 2014; 147: 1517–1523.
37. Potapov EV, Loebe M, Anker S et al. Impact of body mass index on outcome in patients after coronary artery bypass grafting with and without valve surgery. Eur Heart J 2003; 24: 1933–1941.
38. Benderly M, Boyko V, Goldbourt U. Relation of body mass index to mortality among men with coronary heart disease. Am J Cardiol 2010; 106: 297–304.
39. Widlansky ME, Sesso HD, Rexrode KM, Manson JE, Gaziano JM. Body mass index and total and cardiovascular mortality in men with a history of cardiovascular disease. Arch Intern Med 2004; 164: 2326–2332.
40. Domanski MJ, Jablonski KA, Rice MM, Fowler SE, Braunwald E, Investigators P. Obesity and cardiovascular events in patients with established coronary disease. Eur Heart J 2006; 27: 1416–1422.
41. Akin I, Schneider H, Nienaber CA et al. Lack of “obesity paradox” in patients presenting with ST-segment elevation myocardial infarction including cardiogenic shock: a multicenter German network registry analysis. BMC Cardiovasc Disord 2015; 15: 67.
42. Rana JS, Mukamal KJ, Morgan JP, Muller JE, Mittleman MA. Obesity and the risk of death after acute myocardial infarction. Am Heart J 2004; 147: 841–846.
43. Gruberg L, Mercado N, Milo S et al. Impact of body mass index on the outcome of patients with multivessel disease randomized to either coronary artery bypass grafting or stenting in the ARTS trial: the obesity paradox II? Am J Cardiol 2005; 95: 439–444.
44. Galal W, van Gestel YR, Hoeks SE et al. The obesity paradox in patients with peripheral arterial disease. Chest 2008; 134: 925–930.
45. Arabi YM, Dara SI, Tamim HM et al. Clinical characteristics, sepsis interventions and outcomes in the obese patients with septic shock: an international multicenter cohort study. Crit Care 2013; 17: R72.
46. Robinson WR, Furberg H, Banack HR. Selection bias: a missing factor in the obesity paradox debate. Obesity (Silver Spring) 2014; 22: 625.
47. Banack HR, Kaufman JS. Does selection bias explain the obesity paradox among individuals with cardiovascular disease? Ann Epidemiol 2015; 25: 342–349.
48. Vest AR, Wu Y, Hachamovitch R, Young JB, Cho L. The heart failure overweight/obesity survival paradox: the missing sex link. JACC Heart Fail 2015; 3: 917–926.
49. Zeve D, Tang W, Graff J. Fighting fat with fat: the expanding field of adipose stem cells. Cell Stem Cell 2009; 5: 472–481.
50. Das SR, Alexander KP, Chen AY et al. Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-segment elevation myocardial infarction results from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol 2011; 58: 2642–2650.
51. Stokes A, Preston SH. Smoking and reverse causation create an obesity paradox in cardiovascular disease. Obesity (Silver Spring) 2015; 23: 2485–2490.
52. Oreopoulos A, Ezekowitz JA, McAlister FA et al. Association between direct measures of body composition and prognostic factors in chronic heart failure. Mayo Clin Proc 2010; 85: 609–617.
53. Padwal R, McAlister FA, McMurray JJ et al. The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obes (Lond) 2014; 38: 1110–1114.
54. Pocock SJ, Ariti CA, McMurray JJ et al. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J 2013; 34: 1404–1413.
55. Sharma A, Lavie CJ, Borer JS et al. Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. Am J Cardiol 2015; 115: 1428–1434.
56. Fan J, Song Y, Chen Y, Hui R, Zhang W. Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies. Int J Cardiol 2013; 168: 4761–4768.
57. Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann Intern Med 2013; 159: 758–769.
58. Akin I, Tolg R, Hochadel M et al. No evidence of “obesity paradox” after treatment with drug-eluting stents in a routine clinical practice: results from the prospective multicenter German DES.DE (German Drug-Eluting Stent) Registry. JACC Cardiovasc Interv 2012; 5: 162–169.
59. Lainscak M, von Haehling S, Doehner W, Anker SD. The obesity paradox in chronic disease: facts and numbers. J Cachexia Sarcopenia Muscle 2012; 3: 1–4.
60. Stokes A, Preston SH. Revealing the burden of obesity using weight histories. Proc Natl Acad Sci U S A 2016; 113: 572–577.
61. Pozzo J, Fournier P, Lairez O et al. Obesity paradox: origin and best way to assess severity in patients with systolic HF. Obesity (Silver Spring) 2015; 23: 2002–2008.
62. Dixon JB, Egger GJ, Finkelstein EA, Kral JG, Lambert GW. ‘Obesity paradox’ misunderstands the biology of optimal weight throughout the life cycle. Int J Obes (Lond) 2015; 39: 82–84.
63. Ross R, Blair S, de Lannoy L, Despres JP, Lavie CJ. Changing the endpoints for determining effective obesity management. Prog Cardiovasc Dis 2015; 57: 330–336.
64. Porter SA, Massaro JM, Hoffmann U, Vasan RS, O'Donnel CJ, Fox CS. Abdominal subcutaneous adipose tissue: a protective fat depot? Diabetes Care 2009; 32: 1068–1075.
65. Lee CG, Fujimoto WY, Brunzell JD et al. Intra-abdominal fat accumulation is greatest at younger ages in Japanese–American adults. Diabetes Res Clin Pract 2010; 89: 58–64.
66. Gelber RP, Gaziano JM, Orav EJ, Manson JE, Buring JE, Kurth T. Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol 2008; 52: 605–615.
67. Sahakyan KR, Somers VK, Rodriguez-Escudero JP et al. Normal-weight central obesity: implications for total and cardiovascular mortality. Ann Intern Med 2015; 163: 827–835.
68. Coutinho T, Goel K, Correa de Sa D et al. Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol 2011; 57: 1877–1886.
69. Lavie CJ, De Schutter A, Patel DA, Romero-Corral A, Artham SM, Milani RV. Body composition and survival in stable coronary heart disease: impact of lean mass index and body fat in the “obesity paradox”. J Am Coll Cardiol 2012; 60: 1374–1380.
70. Lavie CJ, Parto P, Archer E. Obesity, fitness, hypertension, and prognosis: is physical activity the common denominator? JAMA Intern Med 2016; 176: 217–218.
71. Yerrakalva D, Mullis R, Mant J. The associations of “fatness,” “fitness,” and physical activity with all-cause mortality in older adults: a systematic review. Obesity (Silver Spring) 2015; 23: 1944–1956.
72. Lee DC, Sui X, Artero EG et al. Long-term effects of changes in cardiorespiratory fitness and body mass index on all-cause and cardiovascular disease mortality in men: the Aerobics Center Longitudinal Study. Circulation 2011; 124: 2483–2490.
73. Kodama S, Saito K, Tanaka S et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA 2009; 301: 2024–2035.
74. Gupta S, Rohatgi A, Ayers CR et al. Cardiorespiratory fitness and classification of risk of cardiovascular disease mortality. Circulation 2011; 123: 1377–1383.
75. Lavie CJ, De Schutter A, Milani RV. Healthy obese versus unhealthy lean: the obesity paradox. Nat Rev Endocrinol 2015; 11: 55–62.
76. McAuley PA, Kokkinos PF, Oliveira RB, Emerson BT, Myers JN. Obesity paradox and cardiorespiratory fitness in 12,417 male veterans aged 40 to 70 years. Mayo Clin Proc 2010; 85: 115–121.
77. McAuley PA, Artero EG, Sui X et al. The obesity paradox, cardiorespiratory fitness, and coronary heart disease. Mayo Clin Proc 2012; 87: 443–451.
78. Lavie CJ, Cahalin LP, Chase P et al. Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin Proc 2013; 88: 251–258.
79. Barry VW, Baruth M, Beets MW, Durstine JL, Liu J, Blair SN. Fitness vs. fatness on all-cause mortality: a meta-analysis. Prog Cardiovasc Dis 2014; 56: 382–390.
80. Schunkert H, Harrell L, Palacios IF. Implications of small reference vessel diameter in patients undergoing percutaneous coronary revascularization. J Am Coll Cardiol 1999; 34: 40–48.
81. Kim SH, Despres JP, Koh KK. Obesity and cardiovascular disease: friend or foe? Eur Heart J 2015. doi: 10.1093/eurheartj/ehv509.
82. Arnlov J, Ingelsson E, Sundstrom J, Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010; 121: 230–236.
83. Ortega FB, Lee DC, Katzmarzyk PT et al. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J 2013; 34: 389–397.
84. Bluher M. Are metabolically healthy obese individuals really healthy? Eur J Endocrinol 2014; 171: R209–R219.
85. Tanaka N, Takahashi S, Matsubara T et al. Adipocyte-specific disruption of fat-specific protein 27 causes hepatosteatosis and insulin resistance in high-fat diet-fed mice. J Biol Chem 2015; 290: 3092–3105.
86. Kusminski CM, Holland WL, Sun K et al. MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity. Nat Med 2012; 18: 1539–1549.
87. Hassinen M, Lakka TA, Komulainen P, Haapala I, Nissinen A, Rauramaa R. Association of waist and hip circumference with 12-year progression of carotid intima-media thickness in elderly women. Int J Obes (Lond) 2007; 31: 1406–1411.
88. Mahabadi AA, Berg MH, Lehmann N et al. Association of epicardial fat with cardiovascular risk factors and incident myocardial infarction in the general population: the Heinz Nixdorf Recall Study. J Am Coll Cardiol 2013; 61: 1388–1395.
89. Antonopoulos AS, Margaritis M, Coutinho P et al. Adiponectin as a link between type 2 diabetes and vascular NADPH oxidase activity in the human arterial wall: the regulatory role of perivascular adipose tissue. Diabetes 2015; 64: 2207–2219.
90. Antoniades C, Antonopoulos AS, Tousoulis D, Stefanadis C. Adiponectin: from obesity to cardiovascular disease. Obes Rev 2009; 10: 269–279.
91. Margaritis M, Antonopoulos AS, Digby J et al. Interactions between vascular wall and perivascular adipose tissue reveal novel roles for adiponectin in the regulation of endothelial nitric oxide synthase function in human vessels. Circulation 2013; 127: 2209–2221.
92. Lee MJ, Wu Y, Fried SK. Adipose tissue remodeling in pathophysiology of obesity. Curr Opin Clin Nutr Metab Care 2010; 13: 371–376.
93. Khan T, Muise ES, Iyengar P et al. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol 2009; 29: 1575–1591.
94. Fujisaka S, Usui I, Bukhari A et al. Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 2009; 58: 2574–2582.
95. Sidossis L, Kajimura S. Brown and beige fat in humans: thermogenic adipocytes that control energy and glucose homeostasis. J Clin Invest 2015; 125: 478–486.
96. Stanford KI, Middelbeek RJ, Goodyear LJ. Exercise effects on white adipose tissue: beiging and metabolic adaptations. Diabetes 2015; 64: 2361–2368.